Thiazolidinediones (TZDs), also called glitazones, are synthetic agonists of the peroxisome proliferator-activated receptor gamma (PPARγ) nuclear receptor with potent anti-diabetic efficacy in patients with type 2 diabetes (Soccio et al., 2014). The gene discussed is PPARG; the disease is type 2 diabetes mellitus.